CFTR, the gene product which is defective in patients with cystic fibrosis (CF), functions not only as a C1- channel, but also as a coordinator and regulator of other membrane transporters in epithelia. Identifying and characterizing cellular proteins that interact with CFTR is necessary to understand the regulation of CFTR and its regulatory effects on other membrane transporters. This information could suggest new therapies for CF. This project will examine the consequences of a novel interaction we have discovered between CFTR and AMP-activated protein kinase (AMPK). AMPK is a kinase which is known to respond to the metabolic status of cells, phosphorylating and inhibiting several key biosynthetic enzymes under conditions of nutritional stress, thereby conserving cellular ATP. Its interaction with CFTR may be significant because CFTR is gated by ATP hydrolysis and may mediate ATP release from cells. The regions of both proteins that are important for the interaction will be determined using truncation mutants and the yeast two-hybrid system. AMPK-CFTR binding in vitro and in vivo will be explored through co-immunoprecipitation with epitope-tagged constructs, and conditions that modulate the strength of the interaction will be defined. The functional consequences of the AMPK-CFTR interaction will be studied by: examining the cellular expression and localization of AMPK in relation to CFTR, determining whether CFTR is a substrate for AMPK phosphorylation in vitro and in vivo, investigating the effects of this interaction on CFTR single channel properties and expression in cell membranes using patch-clamp techniques, and determining the effects of the AMPK-CFTR interaction on epithelial Na+ channel (ENaC) function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DK009994-01
Application #
6012961
Study Section
Special Emphasis Panel (ZRG1-BIO (01))
Program Officer
Hyde, James F
Project Start
1999-09-21
Project End
Budget Start
1999-09-21
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hallows, Kenneth R; McCane, Jill E; Kemp, Bruce E et al. (2003) Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells. J Biol Chem 278:998-1004
Hallows, Kenneth R; Kobinger, Gary P; Wilson, James M et al. (2003) Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. Am J Physiol Cell Physiol 284:C1297-308
Hallows, K R; Raghuram, V; Kemp, B E et al. (2000) Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J Clin Invest 105:1711-21